Related Experiment Video
Updated: Jun 19, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Regulatory compliance for point-of-care testing: 2009 United States perspective
Sharon S Ehrmeyer1, Ronald H Laessig
1Clinical Laboratory Science/Medical Technology Program, Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. ehrmeyer@wisc.edu
This paper examines the regulatory compliance of point-of-care testing (POCT) in the United States as of 2009. It explains how the Clinical Laboratory Improvement Amendments (CLIA) set the baseline for all clinical testing, including POCT. However, organizations like the Joint Commission and College of American Pathologists impose additional standards beyond CLIA requirements. The study highlights the challenges of maintaining compliance in decentralized testing environments. It identifies issues such as variability in testing procedures and training needs for POCT personnel. The authors suggest that a more integrated approach is necessary to address these compliance gaps. The findings emphasize the importance of ongoing education and stricter oversight to ensure quality and consistency in POCT settings.
Area of Science:
- Clinical laboratory regulation
- Healthcare compliance management
- Diagnostic testing oversight
Background:
Regulatory oversight of clinical testing in the U.S. has evolved significantly since the introduction of CLIA in 1988. Prior to CLIA, laboratories operated under varied standards depending on location and type of testing. The implementation of CLIA introduced uniform requirements for all clinical testing environments. This shift aimed to improve consistency and quality across diagnostic settings. Hospitals typically rely on inspections by organizations like the Joint Commission or College of American Pathologists to ensure compliance. These entities often impose additional standards beyond CLIA's baseline. Despite these efforts, challenges remain in maintaining compliance, especially in decentralized testing environments. Point-of-care testing (POCT) has introduced new complexities in regulatory adherence. Understanding the evolving landscape of POCT regulation is essential for healthcare providers and laboratory professionals.
Purpose Of The Study:
The purpose of this paper is to assess the regulatory status of point-of-care testing in the United States as of 2009. It aims to clarify how CLIA requirements apply to POCT settings. The study addresses the challenges of ensuring compliance in decentralized testing environments. It highlights the role of organizations like the Joint Commission in enforcing standards beyond CLIA. The focus is on identifying gaps in current regulatory frameworks for POCT. It also examines how these frameworks impact the quality and reliability of diagnostic results. The goal is to provide a comprehensive overview of compliance challenges specific to POCT. This information is intended to guide healthcare professionals in navigating regulatory requirements.
Main Methods:
The authors conducted a review of existing literature and regulatory documents related to CLIA and POCT. They analyzed the requirements set forth by CLIA and compared them with additional standards imposed by organizations like the Joint Commission. The study examined how these standards are applied in practice within hospital settings. It included an evaluation of inspection protocols used by regulatory bodies. The authors also considered the role of accreditation in ensuring compliance. They reviewed case studies and compliance reports from various institutions. The approach involved synthesizing information from multiple sources to identify common themes. This method allowed for a detailed assessment of current regulatory practices.
Main Results:
The study found that CLIA establishes a baseline for all clinical testing, including POCT. However, compliance in POCT settings often requires adherence to additional standards beyond CLIA. The Joint Commission and College of American Pathologists impose stricter requirements in many cases. These organizations conduct regular inspections to ensure compliance with higher standards. The study revealed that POCT environments face unique challenges in maintaining regulatory compliance. These challenges include variability in testing procedures and training requirements. The authors noted that some POCT sites struggle with documentation and quality control. The findings suggest that a coordinated approach is necessary to address compliance gaps in POCT.
Conclusions:
The authors conclude that CLIA provides a foundational framework for regulating clinical testing in the U.S. They emphasize that POCT requires additional oversight to ensure compliance with quality standards. The study highlights the importance of organizations like the Joint Commission in enforcing stricter requirements. It suggests that current regulatory practices may not fully address the unique challenges of POCT. The authors propose that a more integrated approach is needed to improve compliance in decentralized testing environments. They note that ongoing education and training are essential for POCT personnel. The findings indicate that regulatory compliance in POCT remains an area requiring further attention. The study underscores the need for continuous evaluation of existing standards to ensure their effectiveness.
Frequently Asked Questions
The main regulatory framework is the Clinical Laboratory Improvement Amendments of 1988 (CLIA), which sets uniform requirements for all clinical testing environments.
The Joint Commission imposes additional standards beyond CLIA requirements through regular inspections of hospital laboratories.
POCT is decentralized, requiring consistent adherence to CLIA standards in non-laboratory settings, which can be difficult to monitor and enforce.
Accreditation by organizations like the College of American Pathologists helps ensure compliance with standards beyond CLIA requirements.
Common challenges include variability in procedures, documentation issues, and training requirements for personnel conducting tests outside traditional labs.
The authors suggest a coordinated approach involving education, training, and stricter oversight to address compliance gaps in POCT environments.
Related Concept Videos
Legal Guidelines for Documentation
Drug Regulation
Standards of Care II
Standards of Care I
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Control Governance: Regulatory Bodies and Their Impact

